2
INVOTEC® FINAL™ The Final™ answer to nasal dressings... sixty years of proven clinical effectiveness and safety, just got better! Absorbable Nasal Dressing & Pack Invotec International Final™ is formulated to be used as a nasal dressing to prevent adhesions and to stop bleeding. Prevents nasal adhesions. Performs fast and effective hemostasis. Contributes to advanced wound healing. Liquefies in 3 days, absorbs completely in 7-9 days. ms fast and e or f er P ts nasal adh en ev r P . e hemostasis tiv ec eff . esions , s y Liquefies in 3 da o adv es t ibut tr on C ely in 7 omplet bs c , absor . ound healing ed w anc . s y 7-9 da 72xx axis 2pp us a4 5/10/11 14:15 Page 1

INVOTEC® FINAL™ - Axis Medical · INVOTEC® FINAL™ Absorbable Nasal Dressing & Pack Formulated for use after nasal surgery to prevent adhesions and to treat epistaxis. Superior

  • Upload
    others

  • View
    3

  • Download
    0

Embed Size (px)

Citation preview

Page 1: INVOTEC® FINAL™ - Axis Medical · INVOTEC® FINAL™ Absorbable Nasal Dressing & Pack Formulated for use after nasal surgery to prevent adhesions and to treat epistaxis. Superior

INVOTEC® FINAL™

The Final™ answer to nasal dressings...sixty years of proven clinical effectiveness and safety, just got better!

Absorbable Nasal Dressing & Pack

Invotec International Final™ is formulated to be used as a nasal dressing to prevent adhesions and to stop bleeding.

Prevents nasal adhesions.

Performs fast and effective hemostasis.

Contributes to advanced wound healing.

Liquefies in 3 days, absorbs completely in 7-9 days.

ms fast and eorferP

ts nasal adhenevrP

.e hemostasistiveceff

.esions

,syLiquefies in 3 da

o adves tibuttronC

ely in 7ompletbs c, absor

.ound healinged wanc

.sy7-9 da

72xx axis 2pp us a4 5/10/11 14:15 Page 1

Page 2: INVOTEC® FINAL™ - Axis Medical · INVOTEC® FINAL™ Absorbable Nasal Dressing & Pack Formulated for use after nasal surgery to prevent adhesions and to treat epistaxis. Superior

INVOTEC® FINAL™Absorbable Nasal Dressing & Pack

Formulated for use after nasal surgery to prevent adhesions and to treat epistaxis.

Superior Hemostasis1

Collagen gelatin induces the adherence and aggregation of

platelets, which initiates hemo-coagulation and absorbs greater

than 45 times its own weight. Stops bleeding one (1) minute after

insertion.

Direct Wound Healing2

Provides a superior wound-healing environment, not just by

maintaining a moist environment, but also due to its material

composition contributing directly in achieving more rapid healing,

healthier and better structured wounds.

Absorption & Liquification

Final liquefies in 3 days and absorbs completely within

7-9 days.

Intended Use: The Invotec® Final™ Nasal Dressing and Pack is intended to prevent PostOP nasal adhesions (synechecia) and to stop nasal bleeding.

Material Composition: The Invotec® Final™ is made from 100% purified porcine gelatin, especially formulated to be used in ENT procedures.

1 M. Suckfull MD, Ludwig-Maximillan University, Munich, Germany, Clinical Observations: Oct 2009. Document on file.

2 L.Doorn, MSc, Susan Klymowsky MD, The Effect of Gelatin on Wound Healing, Consultative Report, Qserve Amsterdam, Oct, 2009.

0

50

100

150

200

250

300

Invotec Final Collagen Sponge

Geliatin Sponge A

Geliatin Sponge B

Geliatin Sponge C

Active Collagen Sponge

Hem

osta

tic

effic

acy

[%]

(com

pare

dto

absr

bant

gauz

e

Significantly improved hemostatic effacy- Reduced Bleeding Time -

Catalog No. Description Qty/Box

GS805004 Bilateral, Size 80mm x 50mm x 4mm 10

GS802504 Single Side (Small) 80mm x 25mm x 4mm 10

OINV TEC® FIO NAL™

ihi hll

tingelaollagenC

Superior Hemost

ormulated for use after nasal surgery to prevent adhesions and to treat epistaxis.FFormulated for use after nasal surgery to prevent adhesions and to treat epistaxis.

OINV

dilhi i

andeencadhertheesinduc

1tasis

mulated for use after nasal surgery to prevent adhesions and to treat epistaxis.

TEC FIO

bbd

oftionegaraggd

sal surgery to prevent adhesions and to treat epistaxis.

rbbsoANAL

dhesions and to treat epistaxis.

ressal DaNleabb

somehdevorpmiyltnacifingiS

istaxis.

ackg & PPackniss

ycaffffecitats

itroncompositionc

moatainingmain

iosuperavidesorP

ound HeWtecDir

tion.inser

woitstimes45than

inwhich,eletstpla

machievingintlyecdirbuting

dualsobutt,onmenvirenist

onmvirenound-healingwor

2ealing

onbleedingopsStt.eighwwn

andtionoagulac-hemoestitia

,healingapidreor

ialertmaitsotue

ybjustnott,en

ertafeminut(1)e

erteargbsabsord

5

01

51

02

52

03

Hem

osta

tic

effic

acy

[%]

com

pare

dto

absr

bant

gauz

e(

0

0

0

0

0

0

0

laniFcetovnI negalloCegnopS

nitaileGAegnopS

eGopS

somehdevorpmiyltnacifingiS- miTgnideelBdecudeR

nitailBegno

nitaileGCegnopS

evitcAnegalloC

egnopS

ycaffffecitatsem -

ehealthier and bett .oundsed wturer struc

7-

iF

A

.sy-9 da

absoandsyda3inliquefiesinal

tionbsorption & LiquificaA

withinelyompletcbsor

ofofrM

(saP

nI

o be used in ENT pred ttmulaorcineporifiedpur100%om

vnIheTomposition:CerialtaM

op nasal bo stsynechecia) and toPtenevprotendedtinisack

inaFec®otvnIheTse:Uendedtn

.esedurocrespecially tin,gelae

madeisinal™Fec®otv

.bleedingadhesionsnasalostOP

andessingDrNasal al™

swlymo, Susan KcL.Doorn, MS2

aximudwig-M, LM. Suckfull MD1

,ound HealingWtin onelat of Geche EffeT,y MDsk

, Clinical Obsyy, Clinical Obsererman, Munich, Gyy, Munich, Gersitmillan Univ

, 2tdam, Ocermste Av, Qserte ReportivonsultaC

.t on filet 2009. Documentions: Ocavser

009.

Jack

72xx axis 2pp us a4 5/10/11 14:15 Page 2